A randomized clinical trial to determine the efficacy of manufacturers' recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Laidlaw, Maggie ^a   Cockerline, Carla A ^a   Rowe, William J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cardiovascular disease; Omega 3 supplements; Risk biomarkers

Indexed keywords

ASTAXANTHIN; FISH OIL; OMEGA 3 FATTY ACID; SALMON OIL; TOCOPHEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MANUFACTURE; FATTY ACID ANALYSIS; FEMALE; GAS CHROMATOGRAPHY; HUMAN; KRILL; MALE; POPULATION; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RISK REDUCTION; SALMON; ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; MIDDLE AGED; YOUNG ADULT;

EUPHAUSIACEA;

ADULT; ANIMALS; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; EUPHAUSIACEA; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; MIDDLE AGED; TRIGLYCERIDES; YOUNG ADULT;

EID: 84902707146     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-99     Document Type: Article

References (43)

1. Omega-3 fatty acids: their beneficial role in cardiovascular health. Schwalfenberg G, Can Fam Physician 2006 52 734 740 (Pubitemid 44406056)
2. Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Wu JHY, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, Heckbert SR, Siscovick DS, Mozaffarian D, Circulation 2012 125 1084 1093
3. Practical applications of fish oil (ω-3 fatty acids) in primary care. Oh R, J Am Board Fam Pract 2005 18 28 36 (Pubitemid 41657633)
4. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Bucher HC, Hengstler P, Schindler C, Meier G, Am J Med 2002 112 298 304 (Pubitemid 34219443)
5. High dietary and plasma levels of the omega-three fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study. Lopez LB, Kritz-silverstein D, Barrett-Connor E, J Nutr Health Aging 2011 15 1 25 31
6. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M, on behalf of the MIDAS Investigators, Alzheimers Dement 2010 6 456 464
7. n-3 fatty acids and periodontitis in US adults. Navqi AZ, Buettner C, Phillips RS, David RB, Mukamel KJ, J Am Diet Assoc 2010 110 1669 1675
8. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Lee YH, Bae SC, Song GG, Arch Med Res 2012 43 5 356 362
9. Incorporation of n-3 PUFA and γ-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis-a randomized controlled human intervention trial. Dawczynski C, Hackermeier U, Viehweger M, Strange R, Springer M, Jahreis G, Lipids Health Dis 2011 10 130 138
10. Dietary Guidelines for Americans, 2010. United States Department of Agriculture; Department of Health and Human Services, U.S Government printing office Washington, DC, USA, 2010
11. Fish consumption, fish oil, omega-3 fatty acids, and cardio-vascular disease. Kris-Etherton PM, Harris WS, Appel LJ, Committee FTN, Circulation 2002 106 2747 2757 (Pubitemid 35364932)
12. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. Harris WS, Mozaffarian D, Lefevre M, Toner CD, Columbo J, Cunnane SC, Holden JM, Klurfeld DM, Morris MC, Whelan J, J Nutr 2009 139 804S 819S
13. USDA National Nutrient Database for Standard Reference, Release 25. Agricultural Research Service, United States Department of Agriculture (USDA), 2012 USDA Washington, DC, USA
14. Issues of fish consumption for cardiovascular disease risk reduction. Raatz SK, Silverstein JT, Jahns L, Picklo MJ, Nutrients 2013 5 4 1081 1097
15. Serum levels of marine-derived n-3 fatty acids in Icelanders, Japanese, Koreans, and Americans-A descriptive epidemiologic study. Sekikawa A, Steingrimdottir L, Ueshima H, Shin C, Curb JD, Evans RW, Hauksdottir AM, Kadota A, Choo J, Masaki K, Thorsson B, Launer LJ, Garcia ME, Maegawa H, Willcox BJ, Eiriksdottir G, Fujiyoshi A, Miura K, Harris TB, Kuller LH, Gudnason V, Prostaglandins Leukot Essent Fatty Acids 2012 87 11 16
16. Dietary habits in Italy: the importance of the Mediterranean diet. Giraldi G, De Luca dÀlessandro E, Ann Ig 2012 24 4 311 317
17. Survey into the seafood consumption preferences and patterns in the Portuguese population. Gender and regional variability. Cardoso C, Lourenco H, Costa S, Goncalves S, Nunes ML, Appetite 2013 54 20 31
18. Dietary habits, nutrients and bone mass in Spanish premenopausal women: the contribution of fish to better bone health. Calderon-Garcia JF, Moran JM, Roncero-Martin R, Rey-Sanchez P, Rodriguez-Velasco FJ, Pedrera-Zamorano JD, Nutrients 2012 5 1 10 22
19. Dietary habits and ageing in a sample of Italian older people. Guili C, Papa R, Mocchegiani M, Marcellini F, J Nutr Health Aging 2012 16 10 875 879
20. Consumer confidence in supplements remains at two year high: New Survey Results Confirm: Two-thirds of U.S. adults take supplements. www.crnusa.org Council for Responsible Nutrition contact: Nancy Stewart, Washington, D.C. September 20, 2013
21. Absorption of monoacylglycerols by small intestinal brush border membrane. Schulthess G, Lipka G, Compassi S, Boffelli D, Weber FE, Paltauf F, Hauser H, Biochemistry 1994 33 4500 4508 (Pubitemid 24145096)
22. Human absorption of fish oil fatty acids as triglycerides, free acids, or ethyl esters. Lawson L, Hughes B, Biochem Biophys Res Commun 1988 152 1 328 335
23. Eternal absorption in man of eicosapentaenoic acid in different chemical forms. el Boustani S, Colette C, Monnier L, Descomps B, Crastes de Paulet A, Mendy F, Lipids 1987 22 10 711 714 (Pubitemid 18066900)
24. Comparative bioavailability of eicosapentaenoic acid and docosahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers. Beckermann B, Beneke M, Seitz I, Arzneimittelforschung 1990 40 6 700 704 (Pubitemid 20199604)
25. The bioavailability of eicosapentaenoic acid from reconstituted triglyceride fish oil is higher than that obtained from the triglyceride and monoglyceride forms. Wakil A, Mir M, Mellor DD, Mellor SF, Atkin SL, Asia Pac J Clin Nutr 2010 19 4 499 505
26. Bioavailability of marine n-3 fatty acid formulations. Dyerberg J, Madsen P, Moller JM, Aardstrup I, Schmidt EB, Prostaglandins Leukot Essent Fatty Acids 2010 83 3 137 141
27. Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Milte CM, Coates AM, Buckley JD, Hill AM, Howe PR, Br J Nutr 2008 99 5 1083 1088
28. Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. Conquer JA, Holub BJ, J Lipid Res 1998 39 2 286 292 (Pubitemid 28100666)
29. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: the cardiovascular health study. Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, Rimm EB, Wang M, Siscovick DS, Ann Int Med 2013 158 7 515 525
30. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations-a comparative bioavailability study of fish oil vs. krill oil. Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A, Lipids Health Dis 2011 10 145 1 7
31. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova compared to Lovaza in a pharmacokinetic single-dose evaluation) study. Davidson MH, Johnson J, Rooney MW, Kyle ML, Kling DF, J Clin Lipidol 2012 6 6 573 584
32. Blood Levels of long-chain n-3 fatty acids and the risk of sudden death. Albert CM, Campos C, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J, N Engl J Med 2002 346 15) 1113 1118 (Pubitemid 34984601)
33. Serum fatty acids and the risk of coronary heart disease. Simon JA, Hodgkins ML, Browner WS, Neuhaus JM, Bernert JT, Hulley SB, Am J Epidemiol 1995 142 5 469 476
34. N-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS, Am J Clin Nutr 2003 77 2 319 325 (Pubitemid 36133372)
35. The Omega-3 Index: a new risk factor for death from coronary heart disease? Harris WS, von Schacky C, Prev Med 2004 39 1 212 220 (Pubitemid 38797975)
36. Nutritional and botanical modulation of the inflammatory cascade-eicosanoids, cyclooxygenases, and lipooxygenases-as an adjunct in cancer therapy. Wallace J, Integr Cancer Ther 2002 1 1 7 37 (Pubitemid 37101537)
37. Fatty acids form fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Wall R, Ross RP, Fitzgerald GF, Stanton C, Nutr Rev 2010 68 5 280 289
38. Atherosclerosis, dyslipidemia, and inflammation: the significant role of polyunsaturated fatty acids. Dessi M, Noce A, Bertucci P, Manca di Villahermosa S, Zenobi R, Castagnola V, Addessi E, Daniele N, ISRN Inflamm 2013 12 191823
39. The differential effects of EPA and DHA on cardiovascular risk factors. Cottin SC, Sanders TA, Hall WL, Proc Nutr Soc 2011 70 2 215 231
40. Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved. Serini S, Fasano E, Piccioni E, Cittadini AR, Calviello G, Curr Med Chem 2011 18 26 4065 4075
41. Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Wei MY, Jacobson TA, Curr Atheroscler Rep 2011 13 6 474 483
42. EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer's patients. Serini S, Bizzarro A, Piccioni E, Fasano E, Rossi C, Lauria A, Cittadini AR, Masullo C, Calviello G, Curr Alzheimer Res 2012 9 8 913 923
43. Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids. Russell FD, Bürgin-Maunder CS, Mar Drugs 2012 10 11 2535 2559